118 related articles for article (PubMed ID: 17489874)
1. Permeability studies of Kavalactones using a Caco-2 cell monolayer model.
Matthias A; Blanchfield JT; Penman KG; Bone KM; Toth I; Lehmann RP
J Clin Pharm Ther; 2007 Jun; 32(3):233-9. PubMed ID: 17489874
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro.
Mathews JM; Etheridge AS; Valentine JL; Black SR; Coleman DP; Patel P; So J; Burka LT
Drug Metab Dispos; 2005 Oct; 33(10):1555-63. PubMed ID: 16033948
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells.
Whittaker P; Clarke JJ; San RH; Betz JM; Seifried HE; de Jager LS; Dunkel VC
Food Chem Toxicol; 2008 Jan; 46(1):168-74. PubMed ID: 17822821
[TBL] [Abstract][Full Text] [Related]
4. Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1.
Li Y; Mei H; Wu Q; Zhang S; Fang JL; Shi L; Guo L
Toxicol Sci; 2011 Dec; 124(2):388-99. PubMed ID: 21908763
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava).
Unger M; Holzgrabe U; Jacobsen W; Cummins C; Benet LZ
Planta Med; 2002 Dec; 68(12):1055-8. PubMed ID: 12494328
[TBL] [Abstract][Full Text] [Related]
6. Chemical and in vitro toxicity analysis of a supercritical fluid extract of Kava kava (Piper methysticum).
Petersen GE; Tang Y; Fields C
J Ethnopharmacol; 2019 May; 235():301-308. PubMed ID: 30710733
[TBL] [Abstract][Full Text] [Related]
7. Cyclodextrins as carriers for kavalactones in aqueous media: spectroscopic characterization of (S)-7,8-dihydrokavain and beta-cyclodextrin inclusion complex.
Pescitelli G; Bilia AR; Bergonzi MC; Vincieri FF; Di Bari L
J Pharm Biomed Anal; 2010 Aug; 52(4):479-83. PubMed ID: 20185265
[TBL] [Abstract][Full Text] [Related]
8. A UHPLC-UV Method Development and Validation for Determining Kavalactones and Flavokavains in
Tang Y; Fields C
Molecules; 2019 Mar; 24(7):. PubMed ID: 30934989
[TBL] [Abstract][Full Text] [Related]
9. Densitometric analysis of kawain in kava-kava root extracts.
Janeczko Z; Krzek J; Pilewski N; Walusiak D
Acta Pol Pharm; 2001; 58(6):463-8. PubMed ID: 12197620
[TBL] [Abstract][Full Text] [Related]
10. In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones.
Nerurkar PV; Dragull K; Tang CS
Toxicol Sci; 2004 May; 79(1):106-11. PubMed ID: 14737001
[TBL] [Abstract][Full Text] [Related]
11. Determination of kavalactones in dried kava (Piper methysticum) powder using near-infrared reflectance spectroscopy and partial least-squares regression.
Gautz LD; Kaufusi P; Jackson MC; Bittenbender HC; Tang CS
J Agric Food Chem; 2006 Aug; 54(17):6147-52. PubMed ID: 16910700
[TBL] [Abstract][Full Text] [Related]
12. The constituents of Cibotium barometz and their permeability in the human Caco-2 monolayer cell model.
Wu Q; Yang XW
J Ethnopharmacol; 2009 Sep; 125(3):417-22. PubMed ID: 19635547
[TBL] [Abstract][Full Text] [Related]
13. Analysis of kavalactones from Piper methysticum (kava-kava).
Bilia AR; Scalise L; Bergonzi MC; Vincieri FF
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 812(1-2):203-14. PubMed ID: 15556499
[TBL] [Abstract][Full Text] [Related]
14. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro.
Weiss J; Sauer A; Frank A; Unger M
Drug Metab Dispos; 2005 Nov; 33(11):1580-3. PubMed ID: 16051732
[TBL] [Abstract][Full Text] [Related]
15. [Absorption of coptisine chloride and berberrubine across human intestinal epithelial by using human Caco-2 cell monolayers].
Ma L; Yang XW
Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(23):2523-7. PubMed ID: 18330249
[TBL] [Abstract][Full Text] [Related]
16. Composition and biological activity of traditional and commercial kava extracts.
Côté CS; Kor C; Cohen J; Auclair K
Biochem Biophys Res Commun; 2004 Sep; 322(1):147-52. PubMed ID: 15313185
[TBL] [Abstract][Full Text] [Related]
17. Superheated water chromatography-nuclear magnetic resonance spectroscopy of kava lactones.
Chienthavorn O; Smith RM; Wilson ID; Wright B; Lenz EM
Phytochem Anal; 2005; 16(3):217-21. PubMed ID: 15997856
[TBL] [Abstract][Full Text] [Related]
18. Determination of six kavalactones in dietary supplements and selected functional foods containing Piper methysticum by isocratic liquid chromatography with internal standard.
Hu L; Jhoo JW; Ang CY; Dinovi M; Mattia A
J AOAC Int; 2005; 88(1):16-25. PubMed ID: 15759721
[TBL] [Abstract][Full Text] [Related]
19. Effect of the plant matrix on the uptake of luteolin derivatives-containing Artemisia afra aqueous-extract in Caco-2 cells.
Mukinda JT; Syce JA; Fisher D; Meyer M
J Ethnopharmacol; 2010 Aug; 130(3):439-49. PubMed ID: 20609422
[TBL] [Abstract][Full Text] [Related]
20. Interaction of various Piper methysticum cultivars with CNS receptors in vitro.
Dinh LD; Simmen U; Bueter KB; Bueter B; Lundstrom K; Schaffner W
Planta Med; 2001 Jun; 67(4):306-11. PubMed ID: 11458444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
